LYZZ Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

LYZZ Capital is a leading global healthcare-dedicated VC/PE firm. We currently are actively investing out of USD and RMB funds totaling over USD$600million.

Venture capitallyzzcap.comSince 2021-07-15

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$172M

across 1 round

LATEST ROUND

Allotera Therapeutics

Series B · $172M · 2021-07-15

CO-INVESTORS

named beside it

Feed/Investors

Investor

The rounds this investor is named on, who it invests beside, and where it shows up.

BUILT ON

Allotera Therapeutics[ PART ]

Allotera Therapeutics develops allogeneic T-cell therapies targeted at treating various types of blood cancers like leukemia and lymphoma.

Series B$172M2021-07-151 [ HISTORY ]

Company	Round	Amount	Announced	Role
Allotera Therapeutics Allotera Therapeutics develops allogeneic T-cell therapies targeted at treating various types of blood cancers like leukemia and lymphoma.	Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$172M	2021-07-15	[ PART ]

LYZZ Capital

Investor

Rounds

Co-investors

Sectors

Stages

LYZZ Capital

Rounds

Co-investors

Sectors

Stages